Skip to content

Clinical trials

Adenocarcinoma of Lung trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Unknown status Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20143
20165
20171
20183
20192
20202
20211
20224
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
First People's Hospital of Hangzhou2
Henan Cancer Hospital2
Shanghai Pulmonary Hospital, Shanghai, China2
Anhui Provincial Hospital1
Capital Medical University1
Fujian Cancer Hospital1
Geneplus-Beijing Co. Ltd.1
Hui Lin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung26
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms5
Adenocarcinoma, Bronchiolo-Alveolar1
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Bronchogenic1
Carcinoma, Ovarian Epithelial1
Cryptococcosis1
Disease1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.